case report unilateral oral mucous membrane pemphigoid...

4
Case Report Unilateral Oral Mucous Membrane Pemphigoid: Refractory Atypical Presentation Successfully Treated with Intravenous Immunoglobulins André Laureano and Jorge Cardoso Department of Dermatology and Venereology, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central, 1069-166 Lisboa, Portugal Correspondence should be addressed to Andr´ e Laureano; [email protected] Received 25 November 2014; Accepted 2 February 2015 Academic Editor: G´ erald E. Pi´ erard Copyright © 2015 A. Laureano and J. Cardoso. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A 57-year-old male presented with a 6-month history of blisters and painful erosions on the right buccal mucosa. No skin or other mucosal involvement was seen. e findings of histopathological and direct immunofluorescence examinations were sufficient for the diagnosis of oral mucous membrane pemphigoid in the context of adequate clinical correlation. No response was seen aſter topical therapies and oral corticosteroids or dapsone. Intravenous immunoglobulin was started and repeated every three weeks. Complete remission was achieved aſter three cycles and no recurrence was seen aſter two years of follow-up. e authors report a rare unilateral presentation of oral mucous membrane pemphigoid on the right buccal and hard palate mucosa, without additional involvement during a period of five years. Local trauma or autoimmune factors are possible etiologic factors for this rare disorder, here with unique presentation. 1. Introduction Mucous membrane pemphigoid (MMP) describes a hetero- geneous group of chronic autoimmune subepithelial blister- ing diseases, primarily affecting mucous membranes, with or without skin involvement [1]. Although scarring is the clinical hallmark, it may not be obvious in the oral mucosa, which is the most commonly affected site. Lesions typically consist of desquamative gingivitis, erythematous patches, blisters, and erosions covered by pseudomembranes [2]. Autoantibodies binding to the epithelial basement membrane zone (BMZ) have been demonstrated in this subset, targeting bullous antigens 1 and 2, laminin 332 and laminin 311, type VII collagen, 4-integrin subunit, and some nonidentified basal membrane zone antigens [3, 4]. Any oral cavity location can be involved and patients usually have a good prognosis. 2. Case Presentation A 57-year-old male presented with a 6-month history of blisters and painful erosions on the right buccal mucosa. His medical history was relevant for hypertension and hypothy- roidism. He had been taking valsartan and levothyroxine for years and denied the use of topical drugs and previous dental procedures. On physical examination, the patient was found to have few bullae, erosions, and pseudomembrane-covered erosions on the right buccal mucosa (Figure 1). No skin or other mucosal involvement was seen. He had fragmented teeth with sharp edges adjacent to the lesions. Laboratory evaluation was unremarkable. Histopathological examination of bullous lesion revealed a subepithelial blister with a mostly lymphocytic infiltrate in the upper corion (Figure 2). Direct immunofluorescence of peribullous mucosa showed a linear band of IgG, IgA, and complement compo- nent 3 (C3) at the epithelial BMZ (Figure 3). ELISA was negative for antibodies against bullous pem- phigoid antigens 180 and 230 and desmogleins 1 and 3. Correlation between these features allowed the diagnosis of MMP. Application of dipropionate betamethasone cream, twice daily, was started. Aſter one year the patient had Hindawi Publishing Corporation Case Reports in Dermatological Medicine Volume 2015, Article ID 930859, 3 pages http://dx.doi.org/10.1155/2015/930859

Upload: others

Post on 29-Oct-2019

16 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Case Report Unilateral Oral Mucous Membrane Pemphigoid ...downloads.hindawi.com/journals/cridm/2015/930859.pdf · Unilateral Oral Mucous Membrane Pemphigoid: Refractory Atypical Presentation

Case ReportUnilateral Oral Mucous Membrane Pemphigoid:Refractory Atypical Presentation Successfully Treatedwith Intravenous Immunoglobulins

André Laureano and Jorge Cardoso

Department of Dermatology and Venereology, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central,1069-166 Lisboa, Portugal

Correspondence should be addressed to Andre Laureano; [email protected]

Received 25 November 2014; Accepted 2 February 2015

Academic Editor: Gerald E. Pierard

Copyright © 2015 A. Laureano and J. Cardoso. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.

A 57-year-old male presented with a 6-month history of blisters and painful erosions on the right buccal mucosa. No skin or othermucosal involvement was seen. The findings of histopathological and direct immunofluorescence examinations were sufficient forthe diagnosis of oral mucous membrane pemphigoid in the context of adequate clinical correlation. No response was seen aftertopical therapies and oral corticosteroids or dapsone. Intravenous immunoglobulin was started and repeated every three weeks.Complete remission was achieved after three cycles and no recurrence was seen after two years of follow-up. The authors report arare unilateral presentation of oral mucous membrane pemphigoid on the right buccal and hard palate mucosa, without additionalinvolvement during a period of five years. Local trauma or autoimmune factors are possible etiologic factors for this rare disorder,here with unique presentation.

1. Introduction

Mucous membrane pemphigoid (MMP) describes a hetero-geneous group of chronic autoimmune subepithelial blister-ing diseases, primarily affecting mucous membranes, with orwithout skin involvement [1]. Although scarring is the clinicalhallmark, it may not be obvious in the oral mucosa, which isthe most commonly affected site. Lesions typically consist ofdesquamative gingivitis, erythematous patches, blisters, anderosions covered by pseudomembranes [2]. Autoantibodiesbinding to the epithelial basement membrane zone (BMZ)have been demonstrated in this subset, targeting bullousantigens 1 and 2, laminin 332 and laminin 311, type VIIcollagen, 𝛽4-integrin subunit, and some nonidentified basalmembrane zone antigens [3, 4]. Any oral cavity location canbe involved and patients usually have a good prognosis.

2. Case Presentation

A 57-year-old male presented with a 6-month history ofblisters and painful erosions on the right buccal mucosa. His

medical history was relevant for hypertension and hypothy-roidism. He had been taking valsartan and levothyroxine foryears and denied the use of topical drugs and previous dentalprocedures. On physical examination, the patient was foundto have few bullae, erosions, and pseudomembrane-coverederosions on the right buccal mucosa (Figure 1).

No skin or other mucosal involvement was seen. He hadfragmented teeth with sharp edges adjacent to the lesions.Laboratory evaluation was unremarkable. Histopathologicalexamination of bullous lesion revealed a subepithelial blisterwith a mostly lymphocytic infiltrate in the upper corion(Figure 2).

Direct immunofluorescence of peribullous mucosashowed a linear band of IgG, IgA, and complement compo-nent 3 (C3) at the epithelial BMZ (Figure 3).

ELISA was negative for antibodies against bullous pem-phigoid antigens 180 and 230 and desmogleins 1 and 3.Correlation between these features allowed the diagnosis ofMMP. Application of dipropionate betamethasone cream,twice daily, was started. After one year the patient had

Hindawi Publishing CorporationCase Reports in Dermatological MedicineVolume 2015, Article ID 930859, 3 pageshttp://dx.doi.org/10.1155/2015/930859

Page 2: Case Report Unilateral Oral Mucous Membrane Pemphigoid ...downloads.hindawi.com/journals/cridm/2015/930859.pdf · Unilateral Oral Mucous Membrane Pemphigoid: Refractory Atypical Presentation

2 Case Reports in Dermatological Medicine

Figure 1: At presentation multiple painful erosions andpseudomembrane-covered erosions on the right buccal mucosawere seen.

Figure 2: Histopathological examination of a bullous lesionrevealed a subepithelial blister with a mostly lymphocytic andneutrophilic dense inflammatory infiltrate in the upper corion(hematoxylin and eosin, original magnification ×100).

persistent bullae and erosions on the right buccalmucosa thathealedwithout scarring.Oral prednisolone (0.5mg/kg/d)wasstarted for six months, and as no response was achieved,treatment with dapsone (100mg/d) was administered duringone year. Further involvement of the right hard palatemucosaoccurred, erosions were extremely painful, and the patienthad difficulty in eating and depression (Figure 4).

Intravenous immunoglobulin (IVIg) at a dose of2 g/kg/cycle was started and repeated every three weeks.Complete remission was achieved after three cycles. IVIgtherapy was maintained for six additional months. Norecurrence was seen after three years of follow-up (Figure 5).

3. Discussion

The findings of direct immunofluorescence were sufficientfor the diagnosis of MMP in the context of adequate clinicalcorrelation [1]. Patients with MMP with oral involvementoften exhibit bilateral lesions. We reported a unilateralpresentation on the right buccal and hard palate mucosa,without additional involvement during a period of five

Figure 3: Direct immunofluorescence showed a linear band of IgG,IgA, and C3 at the epithelial BMZ (original magnification ×40).

Figure 4: No response after topical and systemic treatment withcorticosteroids and dapsone, with further involvement of the righthard palate mucosa.

Figure 5: Complete response after IVIg therapy and only a delicatewhite pattern of reticulated scarring on the buccal mucosa had beenseen after 3 years of follow-up.

years. A possible previous chronic inflammatory process ofthe mucosa associated with local trauma probably exposedhidden antigens of the BMZ and evoked a secondary autoim-mune response, explaining this mosaic of disease [2]. Directimmunofluorescence findings and the complete responseafter IVIg also suggest an autoimmune etiology, here with

Page 3: Case Report Unilateral Oral Mucous Membrane Pemphigoid ...downloads.hindawi.com/journals/cridm/2015/930859.pdf · Unilateral Oral Mucous Membrane Pemphigoid: Refractory Atypical Presentation

Case Reports in Dermatological Medicine 3

unique presentation [3, 5]. Since management of MMP isoften difficult, our case also shows a complete response to atherapeutic option not commonly used in the limited or lesssevere disease.

Conflict of Interests

The authors declare that there is no conflict of interestsregarding the publication of this paper.

References

[1] L. S. Chan, A. Razzaque Ahmed, G. J. Anhalt et al., “The firstinternational consensus on mucous membrane pemphigoid:definition, diagnostic criteria, pathogenic factors,medical treat-ment and prognostic indicators,” Archives of Dermatology, vol.138, no. 3, pp. 370–379, 2002.

[2] L. S. Chan, “Ocular and oral mucous membrane pemphigoid(cicatricial pemphigoid),” Clinics in Dermatology, vol. 30, no. 1,pp. 34–37, 2012.

[3] A. S. Kourosh and K. B. Yancey, “Pathogenesis of mucousmembrane pemphigoid,”Dermatologic Clinics, vol. 29, no. 3, pp.479–484, 2011.

[4] K. A. Rashid, H. M. Gurcan, and A. R. Ahmed, “Antigen speci-ficity in subsets of mucous membrane pemphigoid,” Journal ofInvestigative Dermatology, vol. 126, no. 12, pp. 2631–2636, 2006.

[5] D. A. Culton and L. A. Diaz, “Treatment of subepidermalimmunobullous diseases,” Clinics in Dermatology, vol. 30, no.1, pp. 95–102, 2012.

Page 4: Case Report Unilateral Oral Mucous Membrane Pemphigoid ...downloads.hindawi.com/journals/cridm/2015/930859.pdf · Unilateral Oral Mucous Membrane Pemphigoid: Refractory Atypical Presentation

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com